Cargando…
Patient‐reported Disease Activity in an Axial Spondyloarthritis Cohort during the COVID‐19 Pandemic
OBJECTIVE: Response to the coronavirus disease 2019 (COVID‐19) pandemic has resulted in shelter‐in‐place orders and major changes to individuals’ daily lives. The impact of such stressors on disease activity in individuals with axial spondyloarthritis (axSpA) is unclear. The aim of this study is to...
Autores principales: | Liew, Jean W., Castillo, Maria, Zaccagnino, Ethan, Katz, Patricia, Haroon, Nigil, Gensler, Lianne S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7504475/ https://www.ncbi.nlm.nih.gov/pubmed/32893508 http://dx.doi.org/10.1002/acr2.11174 |
Ejemplares similares
-
Association of body mass index on disease activity in axial spondyloarthritis: systematic review and meta-analysis
por: Liew, Jean W, et al.
Publicado: (2020) -
A Fifty‐Two–Week, Randomized, Placebo‐Controlled Trial of Certolizumab Pegol in Nonradiographic Axial Spondyloarthritis
por: Deodhar, Atul, et al.
Publicado: (2019) -
Assessing Physical Activity and Sleep in Axial Spondyloarthritis: Measuring the Gap
por: Deodhar, Atul, et al.
Publicado: (2019) -
Efficacy and safety of bimekizumab in axial spondyloarthritis: results of two parallel phase 3 randomised controlled trials
por: van der Heijde, Désirée, et al.
Publicado: (2023) -
COVID-19 Outcomes and Vaccination in Patients with Spondyloarthritis
por: Deodhar, Atul, et al.
Publicado: (2022)